tiprankstipranks
Trending News
More News >
Akeso’s Ivonescimab Gains NMPA Approval for NSCLC Treatment
PremiumCompany AnnouncementsAkeso’s Ivonescimab Gains NMPA Approval for NSCLC Treatment
2M ago
FDA Approves Akeso’s Penpulimab for Advanced Nasopharyngeal Carcinoma
Premium
Company Announcements
FDA Approves Akeso’s Penpulimab for Advanced Nasopharyngeal Carcinoma
2M ago
Akeso’s Ivonescimab Shows Promising Results in Lung Cancer Trial
Premium
Company Announcements
Akeso’s Ivonescimab Shows Promising Results in Lung Cancer Trial
2M ago
Akeso’s Immunotherapy Drugs Join China’s Reimbursement List
PremiumCompany AnnouncementsAkeso’s Immunotherapy Drugs Join China’s Reimbursement List
7M ago
Akeso, Inc. Raises HK$1.924 Billion Through Share Placement
Premium
Company Announcements
Akeso, Inc. Raises HK$1.924 Billion Through Share Placement
9M ago
Akeso, Inc. Aims to Raise HK$1.94 Billion in Share Placement
Premium
Company Announcements
Akeso, Inc. Aims to Raise HK$1.94 Billion in Share Placement
9M ago
Akeso, Inc. Schedules Key Financial Review Meeting
PremiumCompany AnnouncementsAkeso, Inc. Schedules Key Financial Review Meeting
11M ago
Akeso’s Innovative Cancer Drug Advancing Globally
Premium
Company Announcements
Akeso’s Innovative Cancer Drug Advancing Globally
11M ago
Akeso’s Cancer Drug Ivonescimab Shows Promising Trial Results
Premium
Company Announcements
Akeso’s Cancer Drug Ivonescimab Shows Promising Trial Results
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100